Mass Tort Data Intelligence

Real-time docket tracking, filing velocity, and litigation intelligence across 50 active mass tort dockets.

ACTIVE TORTS 50·TOTAL CASES 395,000+·NEW THIS WEEK ~900+·UPCOMING TRIALS 3·Social Media10K+↑·Depo-Provera3.5K+↑↑·Hair Relaxer15.1K↑·Talc / J&J67.2K+→·AFFF / PFAS15.3K+→·Ozempic NAION73+↑↑·PowerPort3K+↑·Lyft Assault170+↑↑·

Market AlertMarch 14, 2026

Post-Bellwether Developments — Social Media MDL 3047 / JCCP 5255

Total Damages

$2.1 Billion

The landmark $2.1B New Mexico state court verdict against Meta and Google (entered March 14, 2026) continues to drive post-verdict momentum across the social media youth addiction docket. Plaintiff firms are leveraging the verdict in federal MDL 3047 bellwether preparation, while defendants signal appellate strategy. Market reaction remains significant with sustained pressure on defendant stock prices.

Defendant Market Impact

META↓ -4.2% since verdict

GOOG↓ -2.8% since verdict

SNAP↓ -6.1% since verdict

PINS↓ -1.4% since verdict

Total Damages

$2.1 Billion

Verdict Breakdown

New Mexico v. Meta Platforms, Inc. et al.

Punitive$1.67B (Meta $1.2B, Google $470M)

Compensatory$430M

NM Concurrent Proceedings

›Post-trial motions deadline: April 14, 2026

›Meta JNOV motion anticipated

›NM AG considering supplemental enforcement action

›Potential impact on 200+ pending state AG actions nationwide

Key Developments

Meta filed Notice of Appeal (NM Court of Appeals) — March 31

Google appeal expected by April 10 deadline

Federal MDL 3047 bellwether trial date confirmed: June 15, 2026

JCCP 5255 (CA state) coordination hearing set April 14

New expert reports filed in MDL 3047 re: algorithmic amplification

Intelligence Feed Network14 active sources

regulatorylegalsciencefinancialnews

CourtListener / PACER50

Google News RSS84

FDA Drug Alerts335

FDA FAERS1,104

PubMed / NCBI67

ClinicalTrials.gov42

JPML MDL Stats28

Class Action Filings19

Market Data56

Federal Register127

CPSC Recalls15

SEC EDGAR38

DOJ / Legal Enforcement22

CDC MMWR31

Total signals:2,018

Polling every 6–12h

Plaintiff Firm Rankings — Mar 29 – Apr 11, 2026

#	Firm	City	Active Dockets	New	Leadership Status
1	Motley Rice LLC	Mt. Pleasant, SC	Social Media, AFFF, Talc	45	PSC — MDL 3047, MDL 2873
2	Levin Papantonio Rafferty	Pensacola, FL	AFFF, Hair Relaxer, PowerPort	38	Co-Lead — MDL 2873
3	Beasley Allen	Montgomery, AL	Paragard, Ozempic, Hair Relaxer	32	PSC — MDL 3094, MDL 2750
4	Seeger Weiss LLP	New York, NY	Acetaminophen, FreeStyle Libre, Social Media	30	Co-Lead — MDL 3043
5	Wisner Baum	Los Angeles, CA	Acetaminophen, Depo-Provera, Social Media	28	PSC — MDL 3043, MDL 3140
6	Slater Slater Schulman	New York, NY	Uber, Lyft, Social Media	25	Lead — MDL 3084
7	TorHoerman Law	Edwardsville, IL	Hair Relaxer, Paragard, Social Media	22	PSC — MDL 3060
8	Weitz & Luxenberg	New York, NY	FreeStyle Libre, 1,4-Dioxane, Talc	20	PSC — MDL 2738

MDL Case Count Tracker — Mar 29 – Apr 11, 2026

50 dockets

Tort	MDL #	Total	New (Wk)	Trend	Key Development
Video Game AddictionOpen Tech	Pre-MDL	~500+	~35	FAST	State AG actions accelerating. Epic Games $520M FTC precedent. MDL formation expected 2026.
Social Media AddictionOpen Tech	3047	10,000+	~30	ACTIVE	Post-verdict momentum. Meta/Google appeal expected. Federal bellwether Jun 15 on track.
Talc / J&JBorderline Consumer	2738	67,200+	~45	FILING	CA $950M verdict vacated Mar 17. Continued high-volume filing.
Hair RelaxerOpen Consumer	3060	~15,100	~25	ACTIVE	BELLWETHER SELECTION: Judge Rowland selected 3 cases Apr 1.
AFFF Firefighting FoamOpen Chemical	2873	15,250+	~40	FILING	Steady high-volume intake. Motley Rice, Levin Papantonio active.
Hernia Mesh (Bard)Open Device	2846	23,800+	~50	FILING	Continued largest filing volume.
Depo-ProveraOpen Pharma	3140	3,490+	~40	FAST	Expert deps completed Mar 20. Preemption motion under advisement.
Suboxone Tooth DecayOpen Pharma	3092	~8,500	~5	FLAT	Bellwether discovery continues.
Ozempic / GLP-1Open Pharma	3094	3,546+	~20	ACTIVE	Entering critical Daubert/SJ phase.
Bard PowerPortOpen Device	3081	3,044+	~40	ACTIVE	TRIAL IMMINENT: Cook bellwether Apr 21.
Paragard IUDBorderline Device	2750	3,600+	~25	FILING	Beasley Allen, TorHoerman active. Mediation ongoing.
Ozempic NAIONOpen Pharma	3163	73+	~19	FAST	Separate MDL created Dec 2025. NJ MCL active in parallel.
Acetaminophen ASDOpen Pharma	3043	~3,025	~25	FILING	Seeger Weiss, Wisner Baum active.
Lyft Sexual AssaultOpen Tech	3171	~170	~20	FAST	Rapid intake continues.
Uber Sexual AssaultOpen Tech	3084	2,075+	~15	FILING	Slater Slater Schulman active.
Cartiva SCIOpen Device	3172	~400	~10	FILING	Mediation ongoing. Bellwether May 26.
Dupixent CTCLOpen Pharma	3180	18+	~5	FAST	JPML MDL motion filed. Ruling expected soon.
Nitrous OxideOpen Consumer	Pre-MDL	~325	~25	FAST	Pre-MDL. Multiple firms active.
FreeStyle LibreOpen Device	Pre-MDL	~215	~15	FILING	Seeger Weiss, Weitz & Luxenberg active.
1,4-DioxaneOpen Chemical	E.D.N.Y	30+	~3	FILING	Weitz & Luxenberg, Napoli Shkolnik active.
ByHeart FormulaOpen Consumer	Pre-MDL	~22	~4	FILING	JPML Birmingham hearing Mar 26. Ruling imminent.
Roundup / MonsantoOpen Chemical	2741	4,200+	~15	ACTIVE	Bayer settlement ongoing. New cases still filing.
Camp Lejeune WaterOpen Chemical	E.D.N.C.	95,000+	~200	FILING	PACT Act claims. Federal government defendant.
Zantac / RanitidineClosed Pharma	2924	2,100+	~2	FLAT	Most claims dismissed. Science rulings unfavorable.
ParaquatOpen Chemical	3004	5,400+	~35	FILING	Parkinson's disease link. Syngenta/Chevron defendants.
Talcum Powder (Cosmetic)Open Consumer	Pre-MDL	~500	~20	FAST	Emerging ovarian cancer claims separate from J&J.
NEC Baby FormulaOpen Consumer	3026	1,800+	~12	ACTIVE	Abbott/Mead Johnson. Premature infant NEC claims.
Tylenol / APAP (Pregnancy)Open Pharma	3043	~3,025	~25	FILING	Autism/ADHD link. Retailers as defendants.
TepezzaOpen Pharma	Pre-MDL	~200	~10	FAST	Hearing loss side effect. Horizon Therapeutics.
Philips CPAPOpen Device	3014	750+	~8	ACTIVE	Foam degradation. Cancer risk claims.
ElmironBorderline Pharma	2973	1,200+	~3	FLAT	Vision damage. Settlement discussions ongoing.
Exactech ImplantOpen Device	3044	900+	~10	FILING	Polyethylene insert failures.
BelviqOpen Pharma	Pre-MDL	~150	~8	FAST	Cancer risk. Pulled from market 2020.
Firefighter CancerOpen Chemical	Pre-MDL	~400	~15	FAST	PFAS exposure. Emerging litigation.
Toxic Baby FoodOpen Consumer	Pre-MDL	~300	~10	FILING	Heavy metals in baby food. Multiple defendants.
FluoroquinoloneBorderline Pharma	Pre-MDL	~250	~2	FLAT	Cipro/Levaquin. Peripheral neuropathy.
Proton Pump InhibitorsClosed Pharma	2789	12,000+	~5	FLAT	Nexium/Prilosec. Kidney damage. Mostly settled.
IVC FilterClosed Device	2641	3,800+	~3	FLAT	Bard/Cook. Filter migration/fracture.
RisperdalClosed Pharma	2767	900+	~2	FLAT	Gynecomastia. Most cases resolved.
3M EarplugsClosed Device	2885	Settled	0	FLAT	$6B settlement complete. Monitoring ongoing.
ValsartanClosed Pharma	2875	1,400+	~3	FLAT	NDMA contamination. Cancer claims.
Juul / E-CigarettesOpen Consumer	3038	4,500+	~15	ACTIVE	Youth vaping. School district claims.
LIV Golf AntitrustOpen Other	Pre-MDL	~50	~3	FAST	Antitrust. PGA merger implications.
Uber Assault (Driver)Open Tech	Pre-MDL	~100	~5	FILING	Driver-on-passenger assault claims.
WeChat PrivacyOpen Tech	Pre-MDL	~75	~4	FAST	Data privacy violations. CCPA claims.
Monsanto PCBOpen Chemical	2342	2,500+	~10	FILING	Environmental contamination. School claims.
Johnson's Baby Powder (Ovarian)Open Consumer	2738	Part of Talc	~20	FILING	Subset of Talc MDL.
Gardasil HPV VaccineOpen Pharma	Pre-MDL	~100	~5	FAST	Autoimmune injury claims. Merck defendant.
Metal-on-Metal HipClosed Device	2244	4,000+	~2	FLAT	DePuy/Stryker. Mostly resolved.
Keytruda Organ FailureOpen Pharma	Pre-MDL	~50	~3	FAST	Immune-related organ failure. Merck defendant.

Critical Dates — Next 60 Days

11 events

Date	Docket	Event	Investor Significance
Apr 1	Hair Relaxer MDL 3060	Bellwether case selection by Judge Rowland	Sets timeline for first federal trial; key valuation signal
Apr 7	Social Media MDL 3047	Expert report deadline — algorithmic amplification	Core liability theory; affects Daubert outcomes
Apr 10	Social Media (NM State)	Google appeal filing deadline	Appellate strategy signals settlement posture
Apr 14	Social Media JCCP 5255	CA state coordination hearing	State-level consolidation affects case volume projections
Apr 14	Social Media (NM State)	Post-trial motions deadline	JNOV ruling could modify $2.1B verdict
Apr 21	Bard PowerPort MDL 3081	Cook Medical bellwether trial begins	First trial in catheter port docket; high settlement leverage
May 5	Depo-Provera MDL 3140	Preemption motion ruling expected	Threshold legal issue — dismissal risk if granted
May 12	Ozempic MDL 3094	Daubert hearing — general causation experts	Make-or-break for GLP-1 litigation viability
May 26	Cartiva SCI MDL 3172	First bellwether trial	Initial trial outcome sets negotiation baseline
Jun 2	Talc MDL 2738	J&J 3rd prepackaged bankruptcy hearing	Could resolve or further delay 67K+ claims
Jun 15	Social Media MDL 3047	Federal bellwether trial begins	Landmark federal trial; massive settlement implications

New Filings — Mar 29 – Apr 11, 2026

Case	Defendant	Court	Theory	Lead Firm
Rodriguez v. Meta Platforms	Meta Platforms, Inc.	N.D. Cal.	Product liability — algorithmic addiction	Motley Rice LLC
Thompson v. Bard Medical	Bard Medical / BD	D. Ariz.	Device failure — catheter fracture	Levin Papantonio
Williams v. Pfizer Inc.	Pfizer Inc.	S.D.N.Y.	Failure to warn — Depo-Provera meningioma	Wisner Baum
Garcia v. Novo Nordisk	Novo Nordisk A/S	E.D. Pa.	GLP-1 gastroparesis / bowel obstruction	Beasley Allen
Davis v. Lyft, Inc.	Lyft, Inc.	N.D. Cal.	Negligent hiring — sexual assault	Slater Slater Schulman
Chen v. Abbott Labs	Abbott Laboratories	N.D. Ill.	Device defect — FreeStyle Libre burns	Seeger Weiss LLP

Investor Intelligence

Analyst Notes & Portfolio Strategy

Priority assessments, stage analysis, and portfolio positioning across active mass tort dockets.

Analyst Notes — Investor Outlook

Social Media Youth Addiction

Elevated Priority

The NM verdict fundamentally shifts the litigation landscape. Federal bellwether on June 15 is the next major catalyst. Expect heightened settlement pressure on Meta/Google. Monitor appellate timeline closely — a sustained verdict dramatically increases portfolio exposure.

View docket details →

Talc / J&J

Bankruptcy Watch

Third prepackaged bankruptcy attempt (June 2 hearing) remains the central variable. CA verdict vacation adds complexity. Resolution of 67K+ claims hinges on bankruptcy court approval of $8.9B trust proposal.

View docket details →

Hair Relaxer

Trial Preparation

Bellwether selections signal active progression. Three cases chosen April 1 will define trial strategy. L'Oreal, Revlon exposure significant. Watch for Daubert rulings on causation experts in coming weeks.

View docket details →

Depo-Provera

Elevated Priority

Preemption ruling (expected May 5) is threshold issue. If denied, rapid case growth likely accelerates. Pfizer exposure could be substantial given long market history and meningioma causation evidence.

View docket details →

Ozempic / GLP-1

Critical Juncture

May 12 Daubert hearing is make-or-break. Favorable ruling opens massive liability exposure for Novo Nordisk and Eli Lilly. Unfavorable ruling could significantly deflate docket. High-stakes binary outcome.

View docket details →

Bard PowerPort

Trial Imminent

Cook Medical bellwether (April 21) is the first catheter port trial. Outcome will set settlement benchmarks. BD/Bard cases to follow. Device failure evidence is strong — favorable plaintiff verdict expected.

View docket details →